Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

CPAC vs CX: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

CPAC Wins Head-to-Head Institutional Verdict (3–2 across 6 Pillars · 8–2 Matrix Metrics)

CPAC Overall Winner 6-Pillar Tally: CPAC 3 – 2 CX (1 Tie) Matrix Metrics: CPAC 8 – 2 CX

As of Nov 16, 2026, Cementos Pacasmayo S.A.A. (CPAC) is the stronger overall head-to-head candidate over Cemex S.A.B. de C.V. (CX) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). CPAC carries a Unified Composite Score of 48.9/100 (HOLD) at $12.92 (15.2x Forward P/E, 25.0% operating margin), whereas CX carries 31.5/100 (SELL) at $10.36 (11.6x Forward P/E, 13.3% operating margin).

  • Technical & Structure Timing Caution: CPAC trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 68.8); meanwhile CX is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 48.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About CPAC vs CX
CPAC NYSE Head-to-Head Winner
Cementos Pacasmayo S.A.A.
Cement, Hydraulic
$12.92
+0.16% 1D
Market Cap $1.1B
TTM Revenue $679M
Forward P/E 15.2x
Beta / 30D Vol 0.18β · 5% Vol
Unified Composite Score
48.9 / 100 HOLD
Tech 32.0 Fund 49.0 Flow 50.0 Mom 31.1
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (2.2% over 20 days), RSI 69
RSI-14: 68.8 · SMA20: $12.78 · SMA50: $12.53
CX NYSE
Cemex S.A.B. de C.V.
Cement, Hydraulic
$10.36
-1.8% 1D
Market Cap $15.2B
TTM Revenue $6.41B
Forward P/E 11.6x
Beta / 30D Vol 1.35β · 33% Vol
Unified Composite Score
31.5 / 100 SELL
Tech 36.0 Fund 40.0 Flow 50.0 Mom 21.1
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -1.3%) with fading momentum, RSI 48
RSI-14: 48.4 · SMA20: $10.58 · SMA50: $10.20

6-Pillar Scorecard Institutional Category Breakdown (CPAC 3 – 2 CX)

Columns: Metric · CPAC · CX
1. Valuation Multiples CX
Forward P/E 15.2x 11.6x
Trailing P/E 14.5x 65.9x
PEG Ratio 1.13x 0.11x
EV / Revenue 1.6x 2.4x
2. Growth & Scale CPAC
Revenue Growth (YoY) +16.3% +8.1%
Earnings Growth (YoY) +69.8% +55.4%
TTM Revenue (USD) $679M $6.41B
Market Cap $1.1B $15.2B
3. Profitability & Quality CPAC
Gross Margin 41.6% 33.5%
Operating Margin 25.0% 13.3%
Net Profit Margin 11.2% 3.6%
Return on Equity (ROE) 18.4% 5.2%
4. Balance Sheet & Cash Flow CPAC
Cash Generation (TTM) $212M EBITDA $1.25B EBITDA
Cash Flow Margin 31.1% EBITDA Mgn 19.6% EBITDA Mgn
Net Cash / Leverage $4.85 Book/Sh · 18.4% ROE $8.90 Book/Sh · 5.2% ROE
Dividend Yield 4.72% None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) 34.4% (70th %ile)
Put/Call OI Skew Thin ADR Chain Thin ADR Chain
OBV Trend / Tech Phase NEUTRAL · Markup NEUTRAL · Distribution
6. R&D & Supply-Chain Moat CX
OpEx & R&D Intensity 16.6% of Rev ($113M) 20.2% of Rev ($1.30B)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role Building Materials Operator Building Materials Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: CPAC (8) vs CX (2)
Institutional Metric CPAC CX Criterion Row Edge
Market Capitalization
Scale
$1.1B $15.2B Larger Scale CX
Trailing P/E Ratio
Valuation
14.5x 65.9x Lower Multiple CPAC
Forward P/E Ratio
Valuation
15.2x 11.6x Lower Multiple CX
Revenue Growth (YoY)
Growth
+16.3% +8.1% Higher Growth CPAC
Operating Margin (TTM)
Profitability
25.0% 13.3% Higher Margin CPAC
Net Profit Margin
Profitability
11.2% 3.6% Higher Margin CPAC
Return on Equity (ROE)
Capital Efficiency
18.4% 5.2% Higher ROE CPAC
52-Week Range Position
Momentum
99% ($6–$13) 24% ($9–$14) Stronger Trend CPAC
Beta / 30D Volatility
Risk Regime
0.18β · 5% Vol 1.35β · 33% Vol Lower Realized Risk CPAC
Unified Institutional Score
Composite Signal
48.9 / 100 (HOLD) 31.5 / 100 (SELL) Higher Composite CPAC
Trailing 12M Revenue (USD)
Operating Scale
$679M $6.41B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
41.6% 33.5% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
1.13x PEG · 1.6x EV/Rev 0.11x PEG · 2.4x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$212M EBITDA ($4.85 Book/Sh · 18.4% ROE) $1.25B EBITDA ($8.90 Book/Sh · 5.2% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CPAC +0.82 pp
CPAC: +1.89% · CX: +1.07%
3M Horizon CPAC +12.77 pp
CPAC: +9.96% · CX: -2.81%
6M Horizon CPAC +40.89 pp
CPAC: +22.46% · CX: -18.43%
1Y Horizon CPAC +77.53 pp
CPAC: +79.2% · CX: +1.67%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CPAC vs CX. Trailing 12-month operating profitability (CPAC 25.0% vs CX 13.3%) and valuation multiples (CPAC 15.2x vs CX 11.6x Forward P/E) are benchmarked directly in Pillar 4 below.

CPAC ADR TTM Benchmark FX-Normalized USD
TTM Revenue$679M
Gross Margin41.6%
Op. Margin25.0%
ROE / Fwd P/E18.4% · 15.2x
CX ADR TTM Benchmark FX-Normalized USD
TTM Revenue$6.41B
Gross Margin33.5%
Op. Margin13.3%
ROE / Fwd P/E5.2% · 11.6x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
CPAC UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew Thin ADR Chain
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact CPAC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
CX UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 34.4%
IV Percentile 70th %ile
Put/Call OI Skew Thin ADR Chain
IV Regime Elevated (60th–80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact CX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
CPAC Moat Profile Scale & Operating Efficiency Moat
Building Materials Operator
Competes within the Building Materials value chain with $1.1B market capitalization and 25.0% operating margin.
OpEx & R&D Reinvestment 16.6% of Rev ($113M)
90D Engineering Disclosures 0 Published
CX Moat Profile Cyclical / Execution-Driven Positioning
Building Materials Operator
Competes within the Building Materials value chain with $15.2B market capitalization and 13.3% operating margin.
OpEx & R&D Reinvestment 20.2% of Rev ($1.30B)
90D Engineering Disclosures 0 Published

Investor FAQ CPAC vs CX Key Questions & Quantitative Answers

As of Nov 16, 2026, Cementos Pacasmayo S.A.A. (CPAC) is the stronger overall head-to-head candidate over Cemex S.A.B. de C.V. (CX) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). CPAC carries a Unified Composite Score of 48.9/100 (HOLD) at $12.92 (15.2x Forward P/E, 25.0% operating margin), whereas CX carries 31.5/100 (SELL) at $10.36 (11.6x Forward P/E, 13.3% operating margin). Technical & Structure Timing Caution: CPAC trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 68.8); meanwhile CX is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 48.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

CPAC leads the Growth & Scale pillar: CPAC posts +16.3% YoY revenue growth and +69.8% YoY earnings growth on $679M TTM revenue (41.6% gross margin, 25.0% operating margin), compared with CX at +8.1% YoY revenue growth and +55.4% YoY earnings growth on $6.41B TTM revenue (33.5% gross margin, 13.3% operating margin). On trailing 12-month operating scale, CPAC generates $679M in USD-normalized revenue versus $6.41B for CX. In operating R&D and SG&A reinvestment, CPAC deploys 16.6% of Rev ($113M) (0 90-day corporate R&D disclosures) versus 20.2% of Rev ($1.30B) (0 disclosures) for CX.

CX screens cheaper on headline valuation multiples. CPAC trades at 15.2x Forward P/E, 14.5x Trailing P/E, 1.13x PEG, and 1.6x EV/Revenue (31.1% EBITDA margin), whereas CX trades at 11.6x Forward P/E, 65.9x Trailing P/E, 0.11x PEG, and 2.4x EV/Revenue (19.6% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CPAC (18.4% ROE) versus CX (5.2% ROE) capital efficiency.

In options market volatility and institutional positioning, CPAC carries N/A implied volatility (N/A, Unclassified), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.18β · 5% Vol realized risk). By comparison, CX carries 34.4% implied volatility (70th %ile, Elevated (60th–80th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.35β · 33% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.